PE20001087A1 - Formulaciones de dosis orales que comprenden (2s,3s,5r)-2-(3,5-difluorofenil)-3,5-dimetil-2-morfolinol y acido alginico - Google Patents
Formulaciones de dosis orales que comprenden (2s,3s,5r)-2-(3,5-difluorofenil)-3,5-dimetil-2-morfolinol y acido alginicoInfo
- Publication number
- PE20001087A1 PE20001087A1 PE1999000976A PE00097699A PE20001087A1 PE 20001087 A1 PE20001087 A1 PE 20001087A1 PE 1999000976 A PE1999000976 A PE 1999000976A PE 00097699 A PE00097699 A PE 00097699A PE 20001087 A1 PE20001087 A1 PE 20001087A1
- Authority
- PE
- Peru
- Prior art keywords
- morpholinol
- difluorophenyl
- dimethyl
- alginic acid
- formulations including
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A FORMULACIONES ORALES QUE COMPRENDE: a)AL MENOS 0.25 mg DE (2S,3S,5R)-2-(3,5-DIFLUOROFENIL)-3,5-DIMETIL-2-MORFOLINOL DE FORMULA I, UNA SAL CLORHIDRATO, UN SOLVATO o UN SOLVATO DE LA SAL; b)AL MENOS 0,2% EN PESO DE UNA CANTIDAD ESTABILIZANTE EFECTIVA DE ACIDO ALGINICO; c)40% A 95% EN PESO DE UN PORTADOR TAL COMO MANITOL, SACAROSA, LACTOSA Y CELULOSA MICROCRISTALINA; d)DE 0,1% A 5% DE UN LUBRICANTE TAL COMO BEHENATO DE GLICERILO, ESTEARATO DE MAGNESIO Y ACIDO ESTEARICO; e)DE 1% A 10% DE UNA GLUCOPIRANOSA O o ß TAL COMO GLICOLATO DE ALMIDON DE SODIO, DE BAJO pH. LAS FORMULACIONES PUEDEN SER UTILES PARA PREVENIR O TRATAR EL TRASTORNO HIPERCINETICO DE LA DEFICIENCIA DE LA ATENCION O DEPRESION, ADICCION A LOS PRODUCTOS QUE CONTIENEN NICOTINA ESPECIALMENTE TABACO
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10211298P | 1998-09-28 | 1998-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20001087A1 true PE20001087A1 (es) | 2000-10-20 |
Family
ID=22288187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999000976A PE20001087A1 (es) | 1998-09-28 | 1999-09-27 | Formulaciones de dosis orales que comprenden (2s,3s,5r)-2-(3,5-difluorofenil)-3,5-dimetil-2-morfolinol y acido alginico |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1117407A1 (es) |
| JP (1) | JP2002525328A (es) |
| KR (1) | KR20010075385A (es) |
| CN (1) | CN1328459A (es) |
| AR (1) | AR022673A1 (es) |
| AU (1) | AU6087399A (es) |
| BR (1) | BR9914096A (es) |
| CA (1) | CA2345638A1 (es) |
| CZ (1) | CZ20011142A3 (es) |
| HU (1) | HUP0103459A2 (es) |
| IL (1) | IL142054A0 (es) |
| MA (1) | MA26693A1 (es) |
| NO (1) | NO20011555L (es) |
| PE (1) | PE20001087A1 (es) |
| PL (1) | PL346877A1 (es) |
| TR (1) | TR200100863T2 (es) |
| WO (1) | WO2000018406A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001026641A2 (en) * | 1999-10-13 | 2001-04-19 | Glaxo Group Limited | Morpholinol derivatives for the treatment of obesity |
| DE102008047910A1 (de) | 2008-09-19 | 2010-03-25 | Molkerei Meggle Wasserburg Gmbh & Co. Kg | Tablettierhilfsstoff auf Laktose- und Cellulosebasis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4597969A (en) * | 1982-04-05 | 1986-07-01 | Merck Sharp & Dohme | Stabilization of unstable drugs or food supplements |
| GB8924528D0 (en) * | 1989-10-31 | 1989-12-20 | Wellcome Found | Heterocyclic pharmaceutical compounds,preparation and use |
-
1999
- 1999-09-23 MA MA25782A patent/MA26693A1/fr unknown
- 1999-09-24 WO PCT/EP1999/007117 patent/WO2000018406A1/en not_active Application Discontinuation
- 1999-09-24 CA CA002345638A patent/CA2345638A1/en not_active Abandoned
- 1999-09-24 CN CN99813675A patent/CN1328459A/zh active Pending
- 1999-09-24 AU AU60873/99A patent/AU6087399A/en not_active Abandoned
- 1999-09-24 EP EP99947420A patent/EP1117407A1/en not_active Withdrawn
- 1999-09-24 KR KR1020017003874A patent/KR20010075385A/ko not_active Application Discontinuation
- 1999-09-24 JP JP2000571924A patent/JP2002525328A/ja active Pending
- 1999-09-24 TR TR2001/00863T patent/TR200100863T2/xx unknown
- 1999-09-24 PL PL99346877A patent/PL346877A1/xx unknown
- 1999-09-24 CZ CZ20011142A patent/CZ20011142A3/cs unknown
- 1999-09-24 HU HU0103459A patent/HUP0103459A2/hu unknown
- 1999-09-24 IL IL14205499A patent/IL142054A0/xx unknown
- 1999-09-24 AR ARP990104841A patent/AR022673A1/es unknown
- 1999-09-24 BR BR9914096-9A patent/BR9914096A/pt not_active IP Right Cessation
- 1999-09-27 PE PE1999000976A patent/PE20001087A1/es not_active Application Discontinuation
-
2001
- 2001-03-27 NO NO20011555A patent/NO20011555L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002525328A (ja) | 2002-08-13 |
| NO20011555D0 (no) | 2001-03-27 |
| CA2345638A1 (en) | 2000-04-06 |
| BR9914096A (pt) | 2001-07-31 |
| MA26693A1 (fr) | 2004-12-20 |
| AU6087399A (en) | 2000-04-17 |
| AR022673A1 (es) | 2002-09-04 |
| TR200100863T2 (tr) | 2001-07-23 |
| CZ20011142A3 (cs) | 2001-09-12 |
| EP1117407A1 (en) | 2001-07-25 |
| IL142054A0 (en) | 2002-03-10 |
| CN1328459A (zh) | 2001-12-26 |
| KR20010075385A (ko) | 2001-08-09 |
| WO2000018406A1 (en) | 2000-04-06 |
| HUP0103459A2 (hu) | 2002-01-28 |
| NO20011555L (no) | 2001-03-27 |
| PL346877A1 (en) | 2002-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9207169A (es) | Composiciones orales para suprimir olores bucales. | |
| CY1106634T1 (el) | Θεραπευτικα παραγωγα της πιπεραζινης | |
| GR3031135T3 (en) | Compositions containing S(+)-Ibuprofen. | |
| YU23599A (sh) | Stabilizovani antihistaminski sirup | |
| KR890011592A (ko) | 기관내 허혈병의 치료용 조성물 | |
| FI943315A0 (fi) | Farmaseuttinen valmiste pore- ja/tai hajoamistabletin tai pikarakeiden muodossa, samoin kuin menetelmä valmistaa niitä | |
| EP1137403A4 (en) | A HYDROCOLLOID AND A DELIVERY-RELATED TABLET CONTAINING CELLULOSE ETHER | |
| KR880006193A (ko) | 피페리딘 화합물 및 그의 제조 및 용도 | |
| IL152932A0 (en) | Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds | |
| UY24308A1 (es) | Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol, para administracion oral | |
| EP1222922A4 (en) | METHOD FOR STABILIZING BENZIMIDAZOLE COMPOUNDS | |
| RU94044456A (ru) | Средство для подавления дисфункционального маточного кровотечения | |
| ES2060173T3 (es) | Derivados de lisolecitina para el tratamiento de enfermedades autoinmunologicas. | |
| PT77991B (en) | Process for the preparation of benzoylurea compounds and pesticidal and pharmaceutical compositions comprising same and for their utilization in the control of insects and/or acarids and for combating tumors in living beings respectively | |
| ES2087623T3 (es) | Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon. | |
| ATE157252T1 (de) | 3'-azido-2',3'-dideoxy-5-methylcytidin enthaltende antivirale zusammensetzungen | |
| TR200000153T2 (tr) | İl-5 inhibite eden 6-azaurasil türevleri. | |
| BR0311642A (pt) | Formulação de divalproex de sódio de liberação aumentada | |
| PE20001087A1 (es) | Formulaciones de dosis orales que comprenden (2s,3s,5r)-2-(3,5-difluorofenil)-3,5-dimetil-2-morfolinol y acido alginico | |
| KR890006625A (ko) | 2,2-디메틸크로멘 유도체, 그의 제조방법 및 그것을 함유하는 약학 조성물 | |
| UA41353C2 (uk) | Похідні алкілбензоїлгуанідинів, спосіб їх одержання, фармацевтична композиція, що має аритмічну активність | |
| CY1104974T1 (el) | Χρηση παραγωγου του διφωσφονικου οξεος για τηn παρασκευη ενος φαρμακου που προοριζεται για τη θεραπεια της χωλοτητας | |
| HUP9903410A2 (hu) | Tolfenámsavat vagy gyógyszerészetileg elfogadható sóját tartalmazó, gyors hatóanyag-leadású tabletta | |
| PT913151E (pt) | Composicoes de luta contra a helicobacter pylori que contem derivados de 1-metilcarbapenem como substancia activa | |
| ES2123808T3 (es) | Derivado de acilfenilglicina y agente profilactico y curativo para enfermedades causadas por una actividad acrecentada de colagenasa, que contiene dicho compuesto como ingrediente activo. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |